Abstract
Scaling up the production of cells in a culture process is a critical step when trying to develop cell-based regenerative therapies. Static cultures often cannot be easily scaled up to clinically relevant cell numbers. Alternatively, bioreactors offer a highly valuable means to develop a clinical-ready process. To culture adherent cells in suspension, such as skin-derived precursor Schwann cells (SKP-SCs), microcarriers need to be used. Microcarriers are small spherical beads suspended within the vessel that allow for higher growth surface area to volume ratio. Here we describe the procedure of combining microcarriers with the controllability of bioreactors to generate higher cell densities in smaller reactor volumes leading to a more efficient and cost-effective cell production for applications in regenerative medicine.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Oudega M, Xu XM (2006) Schwann cell transplantation for repair of the adult spinal cord. J Neurotrauma 23:453–467
Faroni A, Mobasseri SA, Kingham PJ, Reid AJ (2014) Peripheral nerve regeneration: experimental strategies and future perspectives. Adv Drug Deliv Rev 82–83:160–167
Biernaskie J, Sparling JS, Liu J, Shannon CP, Plemel JR, Xie Y, Miller FD, Tetzlaff W (2007) Skin-derived precursors generate myelinating Schwann cells that promote remyelination and functional recovery after contusion spinal cord injury. J Neurosci 27:9545–9559
Khuong HT, Kumar R, Senjaya F, Grochmal J, Ivanovic A, Shakhbazau A, Forden J, Webb A, Biernaskie J, Midha R (2014) Skin derived precursor Schwann cells improve behavioral recovery for acute and delayed nerve repair. Exp Neurol 254:168–179
McKenzie IA, Biernaskie J, Toma JG, Midha R, Miller FD (2006) Skin-derived precursors generate myelinating Schwann cells for the injured and dysmyelinated nervous system. J Neurosci 26:6651–6660
Biernaskie J, McKenzie IA, Toma JG, Miller FD (2006) Isolation of skin-derived precursors (SKPs) and differentiation and enrichment of their Schwann cell progeny. Nat Protoc 1:2803–2812
Kirouac DC, Zandstra PW (2008) The systematic production of cells for cell therapies. Cell Stem Cell 3:369–381
Naing MW, Williams DJ (2011) Three-dimensional culture and bioreactors for cellular therapies. Cytotherapy 13:391–399
Yuan Y, Kallos MS, Hunter C, Sen A (2012) Improved expansion of human bone marrow-derived mesenchymal stem cells in microcarrier-based suspension culture. J Tissue Eng Regen Med 8:210–225
Martin Y, Eldardiri M, Lawrence-Watt DJ, Sharpe JR (2011) Microcarriers and their potential in tissue regeneration. Tissue Eng Part B Rev 17:71–80
Chen AKL, Chen X, Choo ABH, Reuveny S, Oh SKW (2011) Critical microcarrier properties affecting the expansion of undifferentiated human embryonic stem cells. Stem Cell Res 7:97–111
Shakhbazau A, Mirfeizi L, Walsh T, Wobma HM, Kumar R, Singh B, Kallos MS, Midha R (2016) Inter-microcarrier transfer and phenotypic stability of stem cell-derived Schwann cells in stirred suspension bioreactor culture. Biotechnol Bioeng 113:393–402
Acknowledgments
This study was supported by a CRIO Project grant from Alberta Innovates-Health Solutions (AIHS), Project Grant #20140910 to Rajiv Midha, Michael Kallos, and Jeff Biernaskie.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer Science+Business Media New York
About this protocol
Cite this protocol
Walsh, T., Biernaskie, J., Midha, R., Kallos, M.S. (2016). Bioreactor Expansion of Skin-Derived Precursor Schwann Cells. In: Turksen, K. (eds) Bioreactors in Stem Cell Biology. Methods in Molecular Biology, vol 1502. Humana Press, New York, NY. https://doi.org/10.1007/7651_2016_355
Download citation
DOI: https://doi.org/10.1007/7651_2016_355
Published:
Publisher Name: Humana Press, New York, NY
Print ISBN: 978-1-4939-6476-5
Online ISBN: 978-1-4939-6478-9
eBook Packages: Springer Protocols